Purchase Order 75N98026P00992
Award Date 7/13/26
Potential Completion Date 7/12/27
Potential Value $148K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $102,053.00 firm fixed-price purchase order to H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc., a nonprofit hospital and National Cancer Institute-designated comprehensive cancer center, for the procurement of DNA samples to support a multi-ancestry genome-wide association study of lymphoid malignancies. The contract does not utilize any small business set-asides and...
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. The $1,317,908.89 delivery order contract is for the "National Myelodysplastic Syndromes (MDS) Natural History Study - Central Laboratory and Biorepository." The contract has a completion date of June 29, 2018 and did not use any small business set-asides....
- H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. was awarded a delivery order against the National Myelodysplastic Syndromes (MDS) Natural History Study indefinite-delivery/indefinite-quantity contract by the Department of Health and Human Services' National Institutes of Health National Heart, Lung, and Blood Institute. The $928,450.64 delivery order is for central laboratory and biorepository services in support of the MDS Natural History Study, which aims to improve...
- This firm fixed-price purchase order was awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. The $107,968 contract is for the acquisition of cancer biospecimens from the Moffitt Cancer Center to support a multi-ancestry genome-wide association study of lymphoid malignancies. The Moffitt Cancer Center is a nonprofit hospital and the only National...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) for genotyping services. The contract has a ceiling value of $44,499.00 and a completion date of September 2, 2021. The contract was awarded on a sole-source basis and was not set aside for any socioeconomic category....
- This is a federal contract award from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) located in Tampa, Florida. The contract, valued at $15,602,467.00, is focused on early therapeutic development with an emphasis on Phase II clinical trials. The contract is not set aside for any specific business type. Moffitt Cancer Center, a nonprofit, NCI-designated...
- <p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $13,253.75 on November 19, 2020, for the FY26 UDO Initiative.</p> <p>Performance takes place in Rockville, Maryland. The order is firm fixed price with no set-aside designation. Ultimate completion is scheduled for November 30, 2020.</p>
- <p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $24,158.08 on October 19, 2017, with an ultimate completion date of November 19, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific requirements are not detailed in the source material.</p>
- <p>The National Cancer Institute issued a $5,100.20 delivery order to Illumina, Inc. on August 24, 2017, with an ultimate completion date of September 25, 2017.</p> <p>Place of performance is Bethesda, MD 20892. The order is priced on a firm fixed-price basis with no set-aside designation. The source does not specify the parent vehicle or the specific goods or services being delivered under this order.</p>
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., a non-profit, National Cancer Institute-designated comprehensive cancer center located in Tampa, Florida, was awarded a delivery order contract valued at $211,273.45 by the National Heart Lung and Blood Institute on December 3, 2018. This contract falls under the Production Assistance for Cellular Therapies – Cell Processing Facilities (PACT-CPF) master indefinite delivery, indefinite quantity vehicle and specifically supports...
The National Cancer Institute awarded a purchase order to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. valued at $147,750 on July 13, 2026, for corrective editing of splicing factor mutant myelodysplastic syndromes and chronic myelomonocytic leukemia. Performance will be completed by July 12, 2027, at the place of performance in Bethesda, Maryland. The contract is priced on a firm fixed-price basis with no small business set-aside applied.
Generated 7/10/26, 9:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $147.8k | 7/8/26 |